You are here

Devon and Cornwall have approve dasatinib and nilotinib

some of you may remember that around 3/4 weeks ago Devon PCT approved dasatinib and nilotinib for chronic and accelerated phases CML that were resistant to imatinib. See Newswire

I will try to find out what their plans are should NICE go ahead and give a negative FAD in January.

The commissioning group PHTCG obviously did not use the same model as NICE because they came to a different conclusion.

Sandy

The Peninsula Health Technology Commissioning Group (PHTCG) has come to a decision on the use of dasatinib and nilotinib in the management of chronic myeloid leukaemia.

Where clinically appropriate these drugs may be used for patients who are resistant to standard first line therapy with imatinib who are in either the chronic or accelerated phase of the disease.
They may also be used for patients in these phases who cannot tolerate imatinib.

Full text here:
www.devonpct.nhs.uk

Hi sandy, I am on to this already! I have spoken with Devon patient advise & Liason & asked them if they will still fund the drugs. Of course I am worried that they may refuse to fund me any longer, so dont know what I would do then.
I expect to hear from them next week & will let you know as soon as.
Ali

I wrote to them and had the answer that they will continue to fund until the TAG (Technology appraisal guidance) is published by NICE. Then they will follow that guidance.
First there is the ACD...comments in by 7th December.
Then there is the FAD (Final Appraisal Doc) meeting in January 2010 where all comments are accounted for.
Then there is a further period for appeal, not on content of the FAD but on the process..
after this period there is the TAG (April ?).
As soon as the TAG is published that is the official guidance for PCT's to use.

Ali according to the ACD, you will remain on Tasigna for as long as it is clinically effective and working for you.

Sandy